$1.24 Billion is the total value of Davide Leone & Partners Investment Co Ltd.'s 15 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AABA | ALTABA INC | $291,874,000 | -6.4% | 4,207,500 | 0.0% | 23.52% | +2.3% | |
| CELG | CELGENE CORP | $93,180,000 | -2.0% | 1,008,000 | 0.0% | 7.51% | +7.1% | |
| INCY | INCYTE CORP | $62,017,000 | -1.2% | 729,953 | 0.0% | 5.00% | +7.9% | |
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $318,000 | +5.6% | 1 | 0.0% | 0.03% | +18.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 19 | Q3 2023 | 7.8% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q4 2021 | 14.1% |
| BLACKBERRY LTD | 9 | Q4 2021 | 10.1% |
| ILLUMINA INC | 8 | Q4 2020 | 8.8% |
| ENCOMPASS HEALTH CORP | 7 | Q2 2022 | 98.2% |
| INCYTE CORP | 6 | Q1 2021 | 5.0% |
| AMERICAN WELL CORP | 6 | Q4 2021 | 2.7% |
| BIOMARIN PHARMACEUTICAL INC | 5 | Q3 2021 | 9.1% |
| VONTIER CORPORATION | 5 | Q4 2021 | 9.9% |
| QIAGEN NV | 5 | Q1 2021 | 7.7% |
View Davide Leone & Partners Investment Co Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Davide Leone & Partners Investment Co Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.